Nasdaq Stock News

Yahoo Finance chats at length with Nasdaq CEO Adena Friedman about the future of the exchange and her rise to the top leadership position.

Lawmakers talk up ban on Russian oil imports, Apple holds its ‘Peek Performance’ event today, Tesla and car dealers emerge as havens among auto stocks, and other news to start your day.

Share Market News Today | Sensex, Nifty, Share Prices LIVE: BSE Sensex and Nifty 50 were staring at a negative start on Tuesday, as suggested by the trends on SGX Nifty in early trade.

AN2 Therapeutics Inc filed plans on Friday to go public in an initial public offering in which it reportedly hopes to raise about $75 million . AN2 plans to list on the Nasdaq with the symbol of ANTX. The Menlo Park-based biotech is developing a therapy for non-tuberculous mycobacterial (NTM) lung disease, … Full story available on Benzinga.com

American pharmaceutical and biotechnology company Moderna, Inc. has announced plans to build its first African mRNA jab-manufacturing facility in Kenya at a cost of $500 Million. The company said it had signed an agreement with the Kenyan government to produce up to 500 million doses a year by as early as 2023. The NASDAQ listed company said the new facility is expected to produce vaccines for the entire African continent with the possibility of expanding the scope to include finish and packaging capabilities at the site. “Partnerships are key to our goal of deploying vaccines whenever and wherever they are needed,” said Noubar Afeyan, Moderna’s co-Founder and Chairman. “We would like to thank the Government of the Republic of Kenya for their support in bringing our mRNA manufacturing facility to Kenya, and thank the U.S. Government for assisting us in this process. We take seriously our critical role in combatting the COVID-19 pandemic and are determined to expand our global impact with our first manufacturing facility on the continent of Africa.

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® announced that the trading halt status in Nexters Inc. / Nexters Inc. Warrants (Nasdaq: GDEV, GDEVW) was changed to "additional

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® announced that the trading halt status in Yandex N.V. (Nasdaq: YNDX) was changed to "additional information requested" from the

NEW YORK , March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® announced that the trading halt status in Yandex N.V. (Nasdaq: YNDX) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on February 28, 2022 at 06:38:00 Eastern

NEW YORK , March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® announced that the trading halt status in Nexters Inc. / Nexters Inc. Warrants (Nasdaq: GDEV, GDEVW) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on February

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® announced that the trading halt status in HeadHunter Group plc ADS (Nasdaq: HHR) was changed to "additional information request

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® announced that the trading halt status in Ozon Holdings plc ADS (Nasdaq: OZON) was changed to "additional information requested

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® announced that the trading halt status in QIWI plc ADS (Nasdaq: QIWI) was changed to "additional information requested" from th

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® announced that the trading halt status in Ozon Holdings plc ADS (Nasdaq: OZON) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on February 28, 2022 at 06:38:00 Eastern Time at a last sale price of $11.60.

Baudax Bio (BXRX) has regained compliance with Nasdaq''s minimum bid price requirement under Listing Rule 5550(a)(2).Nasdaq staff made this determination of compliance after the…

The company is investing in its future.